Long-Term Trends in Leukemia Subtype Burden in China, 1990-2021

China's leukemia burden from 1990 to 2021 is analyzed for four major subtypes: acute myeloid leukemia (AML), chronic myeloid leukemia (CML), acute lymphoblastic leukemia (ALL), and chronic lymphocytic leukemia (CLL). The dataset, authored by Yudi Shangguan and shared in 2026, uses Global Burden of Disease 2021 data to assess incidence, deaths, and disability-adjusted life years (DALYs), stratified by age and sex.

Use Cases

• Analyze long-term incidence trends for leukemia subtypes based on age-standardized incidence rates (ASIRs) from 1990 to 2021.
• Project future leukemia incidence rates through 2046 based on Bayesian age-period-cohort modeling results.
• Assess the contribution of risk factors like smoking and high body-mass index to leukemia burden based on attributable DALYs.
• Compare epidemiological profiles and age distributions across leukemia subtypes like AML, CML, ALL, and CLL.

Strengths

• Covers a long time series of 32 years (1990-2021) for trend analysis.
• Analyzes four distinct leukemia subtypes with separate epidemiological profiles.
• Includes projections for future incidence rates up to 2046.
• Stratifies data by age and sex, and quantifies burden using multiple metrics like incidence, deaths, and DALYs.

Limitations

• Row count is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• The dataset is very small (14.4 KB), suggesting it may contain summary statistics rather than granular patient-level data.

Provenance

Source

Global Burden of Disease (GBD) 2021 database

Collection Method

Joinpoint regression, age-period-cohort (APC) modeling, and Bayesian APC modeling applied to GBD data.

Time Range

1990 to 2021, with projections to 2046

Freshness

Last updated 2026-06-04 04:32:12; freshness should be verified.

Geography

China